AbCellera Biologics Inc. ABCL United States — Long-term assets
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by AbCellera Biologics Inc. in its filing.
Tagged under the XBRL concept us-gaap:AssetsDesignatedToClosedBlockOtherLongTermInvestments.
The official record: AbCellera Biologics Inc.’s 10-K, filed February 24, 2026, on SEC EDGAR. View the filing →
Ask your AI about AbCellera Biologics Inc.'s united states — long-term assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is AbCellera Biologics Inc.'s united states — long-term assets?
- AbCellera Biologics Inc. (ABCL) reported united states — long-term assets of $532.1M in Q4 2025.
- How has AbCellera Biologics Inc.'s united states — long-term assets changed year-over-year?
- AbCellera Biologics Inc.'s united states — long-term assets increased by 520.9% year-over-year, from $85.7M to $532.1M.
- What does united states — long-term assets mean?
- This metric measures the book value of non-current assets, such as property, plant, equipment, and intangible assets, located or utilized within the United States. It indicates the scale of the company's physical and strategic infrastructure investment required to support its domestic operations. Monitoring this balance provides insight into the capital intensity and long-term operational footprint of the business in this specific region.